July 16, 2019 07:08 AM EDT
Deals

Deal hun­gry So­sei Hep­tares brings Roche's Genen­tech on board as a part­ner

Natalie Grover

Reporter

Japan’s So­sei Hep­tares is stack­ing up key part­ners. On Tues­day, the Tokyo-based com­pa­ny said it had joined forces with Roche’s Genen­tech to de­vel­op med­i­cines that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times